The newly FDA-approved deep brain stimulation (DBS) device will continuously adjust its electrical pulses based on individual brain signals, offering a more personalized and efficient treatment for Parkinson’s patients. This breakthrough in technology aims to improve the balance between medication and stimulation, marking a big shift from the current DBS devices. Read More.
